Dr. Reddy's Laboratories Ltd. (RDY)
12.12
-0.06
(-0.49%)
USD |
NYSE |
Aug 31, 16:00
12.12
0.00 (0.00%)
After-Hours: 16:15
Dr. Reddy's Laboratories Net Income (Quarterly) : 45.92M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 45.92M |
| March 31, 2026 | 24.09M |
| December 31, 2025 | 133.53M |
| September 30, 2025 | 163.44M |
| June 30, 2025 | 164.70M |
| March 31, 2025 | 183.24M |
| December 31, 2024 | 166.24M |
| September 30, 2024 | 160.13M |
| June 30, 2024 | 166.87M |
| March 31, 2024 | 157.40M |
| December 31, 2023 | 165.60M |
| September 30, 2023 | 179.01M |
| June 30, 2023 | 170.64M |
| March 31, 2023 | 116.62M |
| December 31, 2022 | 151.68M |
| September 30, 2022 | 139.43M |
| June 30, 2022 | 153.82M |
| March 31, 2022 | 11.63M |
| December 31, 2021 | 94.26M |
| September 30, 2021 | 133.89M |
| June 30, 2021 | 77.39M |
| March 31, 2021 | 49.72M |
| December 31, 2020 | 2.683M |
| September 30, 2020 | 102.49M |
| June 30, 2020 | 76.36M |
| Date | Value |
|---|---|
| March 31, 2020 | 105.47M |
| December 31, 2019 | -79.98M |
| September 30, 2019 | 155.21M |
| June 30, 2019 | 95.28M |
| March 31, 2019 | 61.61M |
| December 31, 2018 | 67.27M |
| September 30, 2018 | 71.84M |
| June 30, 2018 | 68.05M |
| March 31, 2018 | 46.96M |
| December 31, 2017 | 51.97M |
| September 30, 2017 | 44.19M |
| June 30, 2017 | 9.167M |
| March 31, 2017 | 46.67M |
| December 31, 2016 | 69.43M |
| September 30, 2016 | 44.13M |
| June 30, 2016 | 18.84M |
| March 31, 2016 | 11.05M |
| December 31, 2015 | 87.83M |
| September 30, 2015 | 110.38M |
| June 30, 2015 | 98.59M |
| March 31, 2015 | 83.36M |
| December 31, 2014 | 92.74M |
| September 30, 2014 | 94.15M |
| June 30, 2014 | 92.02M |
| March 31, 2014 | 78.40M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Teva Pharmaceutical Industries Ltd. | -585.89M |
| Takeda Pharmaceutical Co., Ltd. | 710.72M |
| Novo Nordisk A/S | 3.265B |
| Perrigo Co. Plc | 88.50M |
| Innoviva, Inc. | -83.42M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 852.30M |
| Total Expenses (Quarterly) | 805.46M |
| EPS Diluted (Quarterly) | 0.0562 |
| Enterprise Value | 10.08B |
| Gross Profit Margin (Quarterly) | 42.70% |
| Profit Margin (Quarterly) | 5.39% |
| Earnings Yield | 3.67% |
| Operating Earnings Yield | 3.65% |